• A clinical trial reveals that a skin patch, Viaskin, significantly increases peanut tolerance in toddlers with peanut allergies.
• Approximately 67% of children aged one to three wearing the Viaskin patch for a year could safely ingest more peanut protein than before.
• The study, involving 362 toddlers across eight countries, offers hope for a new treatment option where few exist for young children.
• The Viaskin patch represents a potential alternative to strict avoidance, which can significantly impact the quality of life for children and families.